Effects of Consuming Xylitol on Gut Microbiota and Lipid Metabolism in Mice
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- Japan
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Mus musculus
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Response to diet Response to diet,response to diet
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CD (Control diet)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CD-LX (Low dose xylotil group)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Male mice that were given xylitol solution of 40 mg/kg body weight/day on a AIN93G 5% diet.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 5
- Group 1 sample size Number of subjects in the case (exposed) group
- 5
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V2-V3
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Post-Hoc Pairwise
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
Signature 1
Source: Figure 2A
Description: Changes in the fecal microbiota of mice fed 40 ± 5 mg/kg body weight/day (CD-LX), and 194 ± 24 mg/kg body weight/day (CD-MX) of xylitol. An abundance of specific bacterial phylum or genus and ratio after seven weeks of xylitol supplementation.
Abundance in Group 1: increased abundance in CD-LX (Low dose xylotil group)
NCBI | Quality Control | Links |
---|---|---|
Bacillati | ||
Bacteria |
Revision editor(s): YokoC
Signature 2
Source: Figure 2A
Description: Changes in the fecal microbiota of mice fed 40 ± 5 mg/kg body weight/day (CD-LX), and 194 ± 24 mg/kg body weight/day (CD-MX) of xylitol. An abundance of specific bacterial phylum or genus and ratio after seven weeks of xylitol supplementation.
Abundance in Group 1: decreased abundance in CD-LX (Low dose xylotil group)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides |
Revision editor(s): YokoC
Experiment 2
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- CD-MX (medium dose xylotil group)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Male mice that were given xylitol solution of 200 mg/kg body weight/day on a AIN93G 5% fiber diet.
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 2A
Description: Changes in the fecal microbiota of mice fed a control diet (CD) vs mice fed 194 ± 24 mg/kg body weight/day (CD-MX) of xylitol. An abundance of specific bacterial phylum or genus and ratio after seven weeks of xylitol supplementation.
Abundance in Group 1: decreased abundance in CD-MX (medium dose xylotil group)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides |
Revision editor(s): YokoC
Experiment 3
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- HFD (high fat diet)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- HFD-MX (high fat medium dose xylotil)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Male mice that were given xylitol solution of 200 mg/kg body weight/day on a high fat 2.9% fiber diet.
- Group 1 sample size Number of subjects in the case (exposed) group
- 6
Signature 1
Source: Figure 2B
Description: Changes in the fecal microbiota of mice fed a high fat diet (HDF) vs mice fed ad high fat 194 ± 24 mg/kg body weight/day (HDF-MX) of xylitol. An abundance of specific bacterial phylum or genus and ratio after seven weeks of xylitol supplementation.
Abundance in Group 1: increased abundance in HFD-MX (high fat medium dose xylotil)
NCBI | Quality Control | Links |
---|---|---|
Bacteria | ||
Bacillati | ||
Prevotella |
Revision editor(s): YokoC
Signature 2
Source: Figure 2B
Description: Changes in the fecal microbiota of mice fed a high fat diet (HDF) vs mice fed ad high fat 194 ± 24 mg/kg body weight/day (HDF-MX) of xylitol. An abundance of specific bacterial phylum or genus and ratio after seven weeks of xylitol supplementation.
Abundance in Group 1: decreased abundance in HFD-MX (high fat medium dose xylotil)
NCBI | Quality Control | Links |
---|---|---|
Bacteroides |
Revision editor(s): YokoC